Acta Vascular Systems Inc is categorized under Business Services (Unclassified) in San Mateo, CA and active since 2011.
Acta Vascular Systems Inc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Tom Ross at the company’s single location by writing to 712 Prospect Row, San Mateo, California CA 94401 or by phoning (408) 656-1585. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Acta Vascular Systems Inc |
| Contact Person: | Tom Ross |
| Address: | 712 Prospect Row, San Mateo, California 94401 |
| Phone Number: | (408) 656-1585 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Acta Vascular Systems Inc was started in 2011 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Tom Ross for inquiries that concern Acta Vascular Systems Inc by calling the company number (408) 656-1585, as your correspondence is most welcome. Additionally, the physical location of the single location of Acta Vascular Systems Inc can be found at the coordinates 37.573526,-122.338801 as well as the street address 712 Prospect Row in San Mateo, California 94401.
For its online presence, you may visit Acta Vascular Systems Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.